Crowdonomics
WatchlistPortfolio
All companies
ORATRAY logo

ORATRAY

Operating

Oratray, Inc.

Healthcare · Founded 2019

Visit website

Creating healthy smiles

Post-money valuation ⓘ
$6.0M
As of Oct 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$100,000
Crowd $0 · Private $100K · 2 rounds since 2022
Latest share price
$0.41
Section 4(a)(2) · Preferred Stock · Nov 2022 offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$0
−$264K
2022
$0
−$83K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$263,698
-$83,217
Taxes paid
$0
$0
Balance sheet
Cash
$130
$329
Accounts receivable
$0
$0
Total assets
$130
$329
Short-term debt
$0
$302,149
Long-term debt
$218,733
$0
Total liabilities
$218,733
$302,149
Other
Headcount
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$6.0M
pre-money
Reg CF · Common · Jul 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Common Stock · Jul 2024Closedvia StartEngine
Raised $0 / $1.2MInvestors 17Post-money $6M

Team

4 people
Fernando Volante
CEO
Fernando Capriles Belis
CFO
Alejandro Esquivar
Director
Dr. Martin Feo
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 2 annual reports (FY2024–FY2025)

Missing: 2024, 2025

17 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UNov 7, 20240001665160-24-001561
    EDGAR
  • Form CJul 15, 20240001665160-24-001073
    EDGAR
Source: ManualCIK 0002026103Share price $0.48

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.